4-(2-hydroxyethyl)trimethylacetanilide | 180713-45-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(2-hydroxyethyl)trimethylacetanilide
• 英文别名: N-[4-(2-hydroxyethyl)phenyl]-2,2-dimethylpropionamide；N-[4-(2-hydroxyethyl)phenyl]-2,2-dimethylpropanamide
• CAS: 180713-45-5
• 化学式: C₁₃H₁₉NO₂
• 分子量: 221.299
• InChiKey: YXPWKMDHWGVKPR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  49.3
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-(2-hydroxyethyl)trimethylacetanilide 在 戴斯-马丁氧化剂 作用下， 以 二氯甲烷 为溶剂， 反应 3.0h， 生成
  参考文献：
  名称：

  Small, Potent, and Selective Diaryl Phosphonate Inhibitors for Urokinase-Type Plasminogen Activator with In Vivo Antimetastatic Properties

  摘要：

  A set of small nonpeptidic diaryl phosphonate inhibitors was prepared. Some of these inhibitors show potent and highly selective irreversible uPA inhibition. The biochemical and modeling data prove that the combination of a benzylguanidine moiety with a diaryl phosphonate ester results in optimized molecules for derivatizing the serine alcohol in the uPA active site. Selected compounds show significant antimetastatic effects in the BN-472 rat mammary carcinoma model. We report in this paper a preclinical proof of concept that selective, irreversible uPA inhibitors could be valuable in antimetastatic therapy.

  DOI：

  10.1021/jm700962j
• 作为产物：
  描述：

  三甲基乙酰氯 、 4-氨基苯乙醇 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 16.0h， 以78%的产率得到4-(2-hydroxyethyl)trimethylacetanilide
  参考文献：
  名称：

  含有喹啉的组胺H3受体反向激动剂的合成，效价和体内特征。

  摘要：

  开发了组胺H3受体拮抗剂的新结构系列。新化合物基于喹啉核心，并附加了所需的碱性氨乙基部分以及具有调节效能和特性的杂环取代基。类似物在各种体外测定中对大鼠和人H3R具有纳摩尔和亚纳摩尔效价，包括放射性配体竞争结合以及H3受体介导的钙动员和GTPgammaS结合的功能测试。这些化合物具有良好的类药物特性，例如良好的PK，CNS渗透性和跨物种的适度蛋白质结合。发现几种化合物在认知和注意力的动物行为模型中是有效的。

  DOI：

  10.1021/jm0705051

文献信息

• Twisted Amides as Selective Acylating Agents for Hydroxyl Groups under Neutral Conditions:  Models for Activated Peptides during Enzymatic Acyl Transfer Reaction
  作者：Shinji Yamada、Takayuki Sugaki、Kazuhiro Matsuzaki

  DOI：10.1021/jo9522015

  日期：1996.1.1

  The highly twisted amide 2 served as a selective acylating agent; for dials under neutral conditions. The reaction of primary-secondary dials with 2 led to the corresponding primary alkyl monopivalates. For dials containing alcoholic and phenolic hydroxyl groups, alcoholic hydroxyl groups were selectively acylated under neutral conditions, whereas, the opposite selectivity was observed under basic conditions, similar to the cases using acyl halides or acid anhydrides. Although 1 and 3 were unreactive to alcohols, 5-10 having substituent groups at C-4 were reactive to alcohols to give the corresponding acetates or benzoates.
• Small, Potent, and Selective Diaryl Phosphonate Inhibitors for Urokinase-Type Plasminogen Activator with In Vivo Antimetastatic Properties
  作者：Jurgen Joossens、Omar M. Ali、Ibrahim El-Sayed、Georgiana Surpateanu、Pieter Van der Veken、Anne-Marie Lambeir、Buddy Setyono-Han、John A. Foekens、Anneliese Schneider、Wolfgang Schmalix、Achiel Haemers、Koen Augustyns

  DOI：10.1021/jm700962j

  日期：2007.12.27

  A set of small nonpeptidic diaryl phosphonate inhibitors was prepared. Some of these inhibitors show potent and highly selective irreversible uPA inhibition. The biochemical and modeling data prove that the combination of a benzylguanidine moiety with a diaryl phosphonate ester results in optimized molecules for derivatizing the serine alcohol in the uPA active site. Selected compounds show significant antimetastatic effects in the BN-472 rat mammary carcinoma model. We report in this paper a preclinical proof of concept that selective, irreversible uPA inhibitors could be valuable in antimetastatic therapy.
• Synthesis, Potency, and In Vivo Profiles of Quinoline Containing Histamine H₃ Receptor Inverse Agonists
  作者：Robert J. Altenbach、Huaqing Liu、Patricia N. Banfor、Kaitlin E. Browman、Gerard B. Fox、Ryan M. Fryer、Victoria A. Komater、Kathleen M. Krueger、Kennan Marsh、Thomas R. Miller、Jia Bao Pan、Liping Pan、Minghua Sun、Christine Thiffault、Jill Wetter、Chen Zhao、Deliang Zhou、Timothy A. Esbenshade、Arthur A. Hancock、Marlon D. Cowart

  DOI：10.1021/jm0705051

  日期：2007.11.1

  A new structural series of histamine H3 receptor antagonist was developed. The new compounds are based on a quinoline core, appended with a required basic aminoethyl moiety, and with potency- and property-modulating heterocyclic substituents. The analogs have nanomolar and subnanomolar potency for the rat and human H3R in various in vitro assays, including radioligand competition binding as well as

  开发了组胺H3受体拮抗剂的新结构系列。新化合物基于喹啉核心，并附加了所需的碱性氨乙基部分以及具有调节效能和特性的杂环取代基。类似物在各种体外测定中对大鼠和人H3R具有纳摩尔和亚纳摩尔效价，包括放射性配体竞争结合以及H3受体介导的钙动员和GTPgammaS结合的功能测试。这些化合物具有良好的类药物特性，例如良好的PK，CNS渗透性和跨物种的适度蛋白质结合。发现几种化合物在认知和注意力的动物行为模型中是有效的。